Number two vit B1 firm to change hands?
Genex Pharmaceutical has unveiled a plan to buy fellow Chinese company Tianjin Zhongjin Pharmaceutical, one of the world's largest producers of vitamin B1.
Genex Pharmaceutical has unveiled a plan to buy fellow Chinese company Tianjin Zhongjin Pharmaceutical, one of the world's largest producers of vitamin B1.
Companies from Europe, the US and Japan have announced the construction of new facilities this month, suggesting that despite a difficult operating environment big pharma is still making significant capital investments.
The potential to use a phenomenon known as RNA interference (RNAi) to selectively switch off genes associated with disease has captured the attention of drug developers, but as with antisense before it, delivering the agents is the main obstacle.
In-Pharmatechnologist's periodic round-up of personnel moves in the pharmaceutical sector includes a change in leadership at the Association of the British Pharmaceutical Industry and a new managing director at tabletting and tooling company I Holland.